Utilization of enzymes
Abstract
(-- A summary 57) The (correction -- owner) purpose The product which suits the technology of demonstrating a desired function using enzyme, and its purpose is started. An example of such a function is attacking the microbe kind which exists in the microbe phase in a mouth (murder, attack). Example another one more is attacking tumor cells. Composition One or more ビヒクル by which entering in a mouth may be permitted contain two enzyme which has two incomes, and a means to connect these mutually. The substance in which one enzyme generates the intermediate field used with other enzyme, and other enzyme acts on a target region by this -- hypohalous acid salt is generated preferably. It is made for this intermediate field to generate a connection means near the enzyme using intermediate field at this time.
Term
No projected expiry on record.
- Priority
- Filed
- Granted
- Today
66 members in 12 offices
Priority claims2
| Document | Office | Kind | Date |
|---|---|---|---|
| 9006329 | United Kingdom | A | |
| 9021671 | United Kingdom | A |
Members66
| Document | Office | Kind | |
|---|---|---|---|
| GB9006327D0 | United Kingdom | D0 | |
| GB9006328D0 | United Kingdom | D0 | |
| GB9006329D0 | United Kingdom | D0 | |
| GB9021671D0 | United Kingdom | D0 | |
| CA2038577A1 | Canada | A1 | |
| CA2038578A1 | Canada | A1 | |
| CA2038579A1 | Canada | A1 | |
| AU7299591A | Australia | A | |
| AU7299691A | Australia | A | |
| AU7299791A | Australia | A | |
| EP0450800A1 | European Patent Office (EPO) | A1 | |
| EP0451972A1 | European Patent Office (EPO) | A1 | |
| EP0453097A2 | European Patent Office (EPO) | A2 | |
| EP0453097A3 | European Patent Office (EPO) | A3 | |
| BR9101117A | Brazil | A | |
| BR9101118A | Brazil | A | |
| CA2052713A1 | Canada | A1 | |
| EP0479600A2 | European Patent Office (EPO) | A2 | |
| AU8555291A | Australia | A | |
| JPH04234821A | Japan | A | |
| JPH04264036A | Japan | A | |
| ZA912123B | South Africa | B | |
| ZA912124B | South Africa | B | |
| ZA912127B | South Africa | B | |
| EP0479600A3 | European Patent Office (EPO) | A3 | |
| ZA917957B | South Africa | B | |
| JPH0584073A | Japan | A | |
| AU641736B2 | Australia | B2 | |
| JPH05262669A | Japan | A | |
| AU642979B2 | Australia | B2 | |
| AU642980B2 | Australia | B2 | |
| IN172885B | India | B | |
| IN172886B | India | B | |
| IN172887B | India | B | |
| AU653170B2 | Australia | B2 | |
| IN174511B | India | B | |
| EP0453097B1 | European Patent Office (EPO) | B1 | |
| AT131069T | Austria | T | |
| ATE131069T1 | Austria | T1 | |
| DE69115104D1 | Germany | D1 | |
| US5490988A | United States of America | A | |
| ES2082132T3 | Spain | T3 | |
| DE69115104T2 | Germany | T2 | |
| EP0451972B1 | European Patent Office (EPO) | B1 | |
| AT138579TThis record | Austria | T | |
| ATE138579T1 | Austria | T1 | |
| EP0450800B1 | European Patent Office (EPO) | B1 | |
| DE69119817D1 | Germany | D1 | |
| AT139704T | Austria | T | |
| ATE139704T1 | Austria | T1 | |
| DE69120452D1 | Germany | D1 | |
| ES2088463T3 | Spain | T3 | |
| ES2088464T3 | Spain | T3 | |
| DE69119817T2 | Germany | T2 | |
| DE69120452T2 | Germany | T2 | |
| EP0479600B1 | European Patent Office (EPO) | B1 | |
| AT157011T | Austria | T | |
| ATE157011T1 | Austria | T1 | |
| DE69127334D1 | Germany | D1 | |
| ES2106057T3 | Spain | T3 | |
| DE69127334T2 | Germany | T2 | |
| CA2038579C | Canada | C | |
| CA2052713C | Canada | C | |
| JP3098050B2 | Japan | B2 | |
| CA2038578C | Canada | C | |
| CA2038577C | Canada | C |
Numbers
- Application
- 91302396
Titles2
- German
- VERWENDUNG VON ENZYMEN
- English
- USE OF ENZYMES
Classification
- CPC, 6
- A61Q11/00
- A61K8/66
- A61K47/6815
- A61K47/6885
- A61K2800/94
- A61P35/00
- IPC, 8
- A61K38 44
- A61K39 395
- A61K47 48
- A61K8 66
- A61P35 00
- A61Q11 00
- C12N9 04
- C12N9 08